Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Glen Kisby Western University of Health Sciences, College of Osteopathic Medicine of the Pacific Northwest; Lebanon, OR, US

Valerie Palmer Global Health Center, Oregon Health & Science University; Portland, OR US

Mike Lasarev Center for Research on Occupational and Environmental Toxicology, Oregon Health & Science University; Portland, OR US

Rebecca Fry Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina; Chapel Hill, NC US

Mihail Iordanov Department of Cell and Developmental Biology, School of Medicine, Oregon Health & Science University; Portland, OR US

Eli Magun Department of Cell and Developmental Biology, School of Medicine, Oregon Health & Science University; Portland, OR US

Leona Samson Center for Environmental Health Sciences and Biological Engineering Division, Massachusetts Institute of Technology; Cambridge, MA US

Peter Spencer Department of Neurology, School of Medicine, Global Health Center and Center for Research on Occupational and Environmental Toxicology, Oregon Health & Science University; Portland, OR USCorrespondence[email protected]

show all

Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date